ART21934
Asset
Targets TROP2 and delivers a payload that locks PARP onto chromatin, causing DNA double-strand breaks and cell death.
- Stage
- Preclinical
- Modality
- Antibody
- Target
- Not known
- 0
- Indications
- 0
- Trials
- 1
- Developer
Indications
1No named disease
Preclinical, artios.com, 10 Oct 2026
In the full profile
- Owner and partners1
Every asset’s record: target, stage, trials and the evidence behind it.